Showing results (21-30 of 80) with videos related to
Sort By:
Pageof 8
Bone Marrow Transplantation|November 11, 2018
Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced diseaseGerald Wulf, Justin Hasenkamp, Wolfram Jung, et al.Vaccine|July 25, 2006
Cross-presentation of HLA class I epitopes from influenza matrix protein produced in Saccharomyces cerevisiaeAndreas Wadle, Gerhard Held, Frank Neumann, et al.Annals of Hematology|November 26, 2020
Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma-data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin's Lymphoma Study Group)Florian Zettl, Marita Ziepert, Bettina Altmann, et al.Blood|December 4, 2013
Suboptimal dosing of rituximab in male and female patients with DLBCLMichael Pfreundschuh, Carsten Müller, Samira Zeynalova, et al.Clinical Lymphoma, Myeloma & Leukemia|January 31, 2022
Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell LymphomaDominic Kaddu-Mulindwa, Philipp Gödel, Nadine Kutsch, et al.Digestive Diseases and Sciences|March 5, 2014
Proinflammatory progranulin antibodies in inflammatory bowel diseasesLorenz Thurner, Elisabeth Stöger, Natalie Fadle, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphomaGerhard Held, Niels Murawski, Marita Ziepert, et al.Blood|July 28, 2011
Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2AKlaus-Dieter Preuss, Michael Pfreundschuh, Natalie Fadle, et al.The Journal of Biological Chemistry|November 13, 2004
A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3Martin Hülsmeyer, Patrick Chames, Roman C Hillig, et al.International Journal of Cancer|January 21, 2014
Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MMCarsten Zwick, Gerhard Held, Michaela Auth, et al.Pageof 8